Stability & Formulation Development Service for Veterinary (Pet) Antibody

Are you facing challenges with antibody aggregation, loss of potency, or achieving a commercially viable shelf-life for your veterinary biologic? Creative Biolabs' stability & formulation development service helps you create stable, effective, and safe antibody formulations for companion animals. Through high-throughput screening and advanced biophysical characterization, we mitigate development risks and accelerate your path to delivering next-generation pet therapeutics.

Introduction

Creative Biolabs specializes in transforming promising veterinary antibody candidates into stable, developable drug products. Our core objective is to design a formulation that maintains the antibody's structural integrity, biological activity, and safety profile throughout its intended shelf life and under various stress conditions. We deliver optimized liquid or lyophilized formulations ready for pivotal preclinical toxicology studies and scalable for future manufacturing, ensuring your therapeutic is primed for success. Our team works as a dedicated partner, providing the critical data and formulation expertise needed to advance your project with confidence.

Discover How We Can Help - Request a Consultation

Workflow

Fig 1. Pet Therapeutic Antibody Stability & Formulation Development Service Workflow. (Creative Biolabs Original)

Workflow	Description
Project Consultation & Requirement Analysis	We start with a detailed discussion to understand your antibody's intended veterinary application, target species, administration route, storage requirements, and regulatory considerations.
Pre-Formulation Characterization	Comprehensive analysis of antibody physicochemical properties (including solubility, isoelectric point, aggregation tendency, and thermal stability) forms the foundation for rational formulation design.
Formulation Design & Excipient Screening	Multiple formulation candidates are designed, incorporating suitable buffers, stabilizers, and excipients to enhance antibody stability, prevent aggregation, and maintain biological activity.
Stress Testing & Stability Studies	Formulation candidates are subjected to stress conditions (temperature, agitation, freeze-thaw cycles, light exposure) to assess physical and chemical stability over time.
Accelerated & Real-Time Stability Evaluation	Both accelerated and real-time stability studies are performed under relevant storage conditions to predict shelf life and identify optimal formulation parameters.
Data Analysis & Optimization	Results are analyzed to refine the formulation, ensuring it meets target stability profiles and retains efficacy throughout intended shelf life and distribution.
Final Formulation & Documentation	The optimized formulation is finalized with complete technical documentation, including process parameters, stability data, and recommendations for scale-up.

Why Choose Us?

Veterinary-Specific Expertise
Our team designs formulations optimized for the unique physiological conditions and administration routes in target companion animals, ensuring safety and efficacy across species.
Comprehensive Stability Assessment
We integrate accelerated, real-time, and stress-condition studies to provide a complete stability profile, reducing the risk of product degradation during storage and transport.
Customizable Solutions
Every formulation is tailored to the antibody's unique biochemical properties and intended application, avoiding a one-size-fits-all approach.
Scale-Up Ready
Our processes are designed with downstream manufacturing in mind, ensuring smooth transition from small-scale development to commercial production.

Antibody Stability & Formulation Development. (Creative Biolabs Authorized)

FAQs

1. Can you develop both liquid and lyophilized (freeze-dried) formulations?

Absolutely. We have extensive experience in developing both stable liquid formulations for ease of use and lyophilized formulations for antibodies that may have inherent long-term stability challenges in a liquid state. The choice depends entirely on your antibody's properties and your target product profile.

2. How do you ensure the excipients used are safe for companion animals?

We prioritize the use of excipients that are Generally Recognized as Safe (GRAS) and have a long history of use in approved parenteral drug products for both human and veterinary medicine. We provide a full list of all components for your review and toxicological assessment.

Related Services

Achieve your preclinical goals with our integrated suite of antibody development services.

Developability Evaluation and Optimization

We assess the inherent drug-like properties of your antibody candidate early on to de-risk downstream development.

Cell Line Development

Generate high-yield, stable cell lines tailored for veterinary therapeutic antibody production.

Cell Culture Process Development

Design and optimize scalable cell culture processes from small-scale to pilot production.

Antibody Purification

We design and implement scalable, efficient downstream purification strategies to achieve high purity and yield.

Non-GMP Production

Our facilities can produce high-quality antibody material sufficient for all your preclinical research and analytical needs.

Partner with Creative Biolabs

Creative Biolabs provides comprehensive, end-to-end support for veterinary antibody development, with a specialized focus on creating robust and commercially viable formulations. Our dedicated team combines deep scientific expertise with state-of-the-art technology to accelerate your program and mitigate risks.

Ready to ensure the stability and success of your therapeutic antibody? Reach out to our scientific team to discuss your project-specific needs. Contact our team for more information and to discuss your antibody stability and formulation development project.

Contact Our Team for More Information and to Discuss Your Project.

Services